Fenom Pro
Jun 2023
569d
Caire Diagnostics, Inc. has submitted 1 FDA 510(k) premarket notifications since 2023, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include System, Test, Breath Nitric Oxide . Use the specialty filter in the sidebar to narrow results.